Another attempt

[JP1952]

birmingham.ac.uk/news/2023/...

[Turfbeg]

Many thanks for posting this article!

[john0084]

Really good news for all pv patients in the UK.

[LittleLuna]

thank you for sharing 😀

[Manouche]

… »For some time we have wanted to be able to understand the long-term benefits of a drug such as ruxolitinib for patients with PV. This study shows several important messages about this therapy which will hopefully shortly be available for UK patients ».

[EPguy]

This is fresh stuff. I recently posted some thoughts on the trial.

This part is new: "For the first time ever using samples from the study the researchers showed that both controlling the blood count and reducing mutated JAK2 by 50% led to fewer disease related events" For IFN it's been implicit but has never been an endpoint of a trial.

healthunlocked.com/mpnvoice...

They refer to Rux as "new". It's been in use for over 10 years, but first for MF. What's new is all the data for PV just coming out.

[Anouchka in reply to EPguy]

that’s interesting! I consider myself lucky it’s available here in France having been diagnosed with PV last year….

[ciye]

That is good news.

[Maisie10]

many thanks for sharing. Good news. Hopefully soon available in the uk. Take care

[STK52]

Thanks for sharing. Is Rux available for PV patients as second or third line option in the UK? Does anyone know?

[william-Indo]

Thank you for the post

[MAP44]

More great studies to benefit all of us.

🙂🎉🥂

[T1960]

A great article, very positive for all of us with PV. Question - how are we chosen for a trial? - anybody.